0 items USD 0.00Search
- Did you mean
- ruxolitinib
Your search for "tofacitinib" gave back 50 results.
The global Tofacitinib market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %...
颁补迟补濒辞驳:听
MRRPB5
December 2024
Price: USD 4,900.00
The global Generic Tofacitinib market size is predicted to grow from US$ 1049 million in 2025 to US$ 1464 million in 2031; it is expected to grow at...
颁补迟补濒辞驳:听
LPI
February 2025
Price: USD 3,660.00
The global market for Generic Tofacitinib was valued at US$ 1022 million in the year 2024 and is projected to reach a revised size of US$ 1479...
颁补迟补濒辞驳:听
MRRPB5
February 2025
Price: USD 2,900.00
Tofacitinib, also known as Xeljanz, is a type of drug known as a Janus kinase (JAK) inhibitor. It works by blocking the action of Janus kinase...
颁补迟补濒辞驳:听
MRRPB5
November 2024
Price: USD 4,900.00
Tofacitinib citrate is a medication used to treat autoimmune diseases, primarily rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis...
颁补迟补濒辞驳:听
LPI
October 2024
Price: USD 3,660.00
Tofacitinib citrate extended-release tablets refer to a specific pharmaceutical formulation of tofacitinib citrate,a Janus kinase(JAK)inhibitor used...
颁补迟补濒辞驳:听
LPI
November 2024
Price: USD 3,660.00
Tofacitinib citrate is a medication used to treat autoimmune diseases, primarily rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis...
颁补迟补濒辞驳:听
MRRPB5
September 2024
Price: USD 2,900.00
The global Tofacitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the...
颁补迟补濒辞驳:听
MRRPB5
May 2024
Price: USD 2,900.00
Tofacitinib Citrate Tablets is an immunosuppressant, which affects the cellular hematopoietic process and cellular immune function by conducting the...
颁补迟补濒辞驳:听
MRRPB5
August 2024
Price: USD 2,900.00
The global Generic Tofacitinib market was valued at US$ 936.4 million in 2023 and is anticipated to reach US$ 1342.7 million by 2030, witnessing a...
颁补迟补濒辞驳:听
MRRPB5
April 2024
Price: USD 2,900.00
Tofacitinib citrate extended-release tablets refer to a specific pharmaceutical formulation of tofacitinib citrate,a Janus kinase(JAK)inhibitor used...
颁补迟补濒辞驳:听
MRRPB5
August 2024
Price: USD 2,900.00
Tofacitinib, also known as Xeljanz, is a type of drug known as a Janus kinase (JAK) inhibitor. It works by blocking the action of Janus kinase...
颁补迟补濒辞驳:听
MRRPB5
April 2024
Price: USD 2,900.00
Highlights The global Tofacitinib market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of %...
颁补迟补濒辞驳:听
MRRPB5
April 2023
Price: USD 2,900.00
Highlights The global Generic Tofacitinib market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR...
颁补迟补濒辞驳:听
MRRPB5
January 2023
Price: USD 2,900.00
The global Janus Kinase (JAK) Inhibitors market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030...
颁补迟补濒辞驳:听
GIR
August 2024
Price: USD 3,480.00
听
